[go: up one dir, main page]

SK109399A3 - 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same - Google Patents

3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same Download PDF

Info

Publication number
SK109399A3
SK109399A3 SK1093-99A SK109399A SK109399A3 SK 109399 A3 SK109399 A3 SK 109399A3 SK 109399 A SK109399 A SK 109399A SK 109399 A3 SK109399 A3 SK 109399A3
Authority
SK
Slovakia
Prior art keywords
group
carbon atoms
compound
solution
ethyl acetate
Prior art date
Application number
SK1093-99A
Other languages
English (en)
Slovak (sk)
Inventor
Motohide Sato
Takeo Katsushima
Hajime Kinoshita
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of SK109399A3 publication Critical patent/SK109399A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1093-99A 1997-12-12 1998-12-11 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same SK109399A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP36281997 1997-12-12
JP10288979A JP2959765B2 (ja) 1997-12-12 1998-10-12 ３−ピペリジル−４−オキソキナゾリン誘導体及びそれを含有してなる医薬組成物
PCT/JP1998/005628 WO1999031085A1 (en) 1997-12-12 1998-12-11 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same

Publications (1)

Publication Number Publication Date
SK109399A3 true SK109399A3 (en) 2000-01-18

Family

ID=26557408

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1093-99A SK109399A3 (en) 1997-12-12 1998-12-11 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same

Country Status (18)

Country Link
US (1) US6235730B1 (ja)
EP (1) EP0970954A4 (ja)
JP (1) JP2959765B2 (ja)
KR (1) KR20000070983A (ja)
CN (1) CN1252068A (ja)
AR (1) AR009212A1 (ja)
AU (1) AU717963B2 (ja)
BR (1) BR9807339A (ja)
CA (1) CA2280705A1 (ja)
HU (1) HUP0001154A3 (ja)
ID (1) ID23439A (ja)
IL (1) IL131319A0 (ja)
NO (1) NO993868L (ja)
NZ (1) NZ337118A (ja)
PE (1) PE20000054A1 (ja)
SK (1) SK109399A3 (ja)
TR (1) TR199901933T1 (ja)
WO (1) WO1999031085A1 (ja)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767739B2 (en) 2001-07-30 2004-07-27 Isis Pharmaceuticals Inc. Antisense modulation of microsomal triglyceride transfer protein expression
US20040122011A1 (en) * 1998-12-23 2004-06-24 Pharmacia Corporation Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
USPP12295P2 (en) * 1999-06-01 2001-12-18 Florfis Ag Geranium plant named ‘Fiscoral’
US6258819B1 (en) * 1999-08-05 2001-07-10 Syntex (U.S.A.) Llc Substituted 2(4-piperidyl)-4(3H)-quinazolinones and 2-(4-piperidyl)-4(3H)-azaquinazolinones
JP2003104971A (ja) * 1999-08-12 2003-04-09 Wakunaga Pharmaceut Co Ltd 新規アニリド誘導体又はその塩及びこれを含有する医薬
US6800651B2 (en) 2000-02-03 2004-10-05 Eli Lilly And Company Potentiators of glutamate receptors
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US6489125B1 (en) * 2000-05-10 2002-12-03 The Trustees Of Columbia University In The City Of New York Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
US20040048780A1 (en) * 2000-05-10 2004-03-11 The Trustees Of Columbia University In The City Of New York Method for treating and preventing cardiac arrhythmia
US7879840B2 (en) * 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7393652B2 (en) * 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US7718644B2 (en) * 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US20060293266A1 (en) * 2000-05-10 2006-12-28 The Trustees Of Columbia Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
PL367680A1 (en) * 2001-06-28 2005-03-07 Pfizer Products Inc. Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion
CA2460682C (en) 2002-02-28 2010-11-30 Japan Tobacco Inc. Ester compound and medical use thereof
US7544678B2 (en) * 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
AU2004220548A1 (en) 2003-03-07 2004-09-23 The Trustees Of Columbia University, In The City Of New York Type 1 ryanodine receptor-based methods
EP1669345A4 (en) 2003-08-29 2008-02-20 Japan Tobacco Inc ESTER DERIVATIVE AND MEDICAL USE THEREOF
CN1863778A (zh) * 2003-10-08 2006-11-15 伊莱利利公司 用于治疗血脂异常的化合物及方法
US8710045B2 (en) * 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7378426B2 (en) * 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7417040B2 (en) * 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US20060030623A1 (en) * 2004-07-16 2006-02-09 Noboru Furukawa Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
US8101774B2 (en) 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
WO2006046623A1 (ja) * 2004-10-25 2006-05-04 Japan Tobacco Inc. 溶解性及び安定性の改善された固形製剤及びその製造方法
JP2008542255A (ja) * 2005-05-27 2008-11-27 ファイザー・プロダクツ・インク 肥満症の治療または体重減量の維持のためのカンナビノイド−１受容体アンタゴニストおよびミクロソームトリグリセリド輸送タンパク質阻害物質の併用
US7704990B2 (en) * 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
WO2007056388A2 (en) * 2005-11-07 2007-05-18 The General Hospital Corporation Compositions and methods for modulating poly (adp-ribose) polymerase activity
EP2727585A1 (en) 2006-05-16 2014-05-07 Takeda Pharmaceutical Company Limited In-vivo screening method
WO2007141029A1 (en) * 2006-06-08 2007-12-13 Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Specific protease inhibitors and their use in cancer therapy
EP2079739A2 (en) * 2006-10-04 2009-07-22 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
US8735391B2 (en) 2008-09-26 2014-05-27 University Of Kansas Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
WO2014102592A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Oxime/substituted quinoxaline-type piperidine compounds and uses thereof
JP7471818B2 (ja) * 2016-08-18 2024-04-22 ヴィダック ファーマ リミテッド ピペラジン誘導体、医薬組成物、及びその使用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1583753A (en) * 1976-07-14 1981-02-04 Science Union & Cie Piperidine derivatives processes for their preparation and pharmaceutical compositions containing them
US4292321A (en) 1979-05-24 1981-09-29 Warner-Lambert Company 1,3,8-Triazaspirodecane-4-ones, pharmaceutical compositions thereof and method of use thereof
US4364954A (en) 1980-01-10 1982-12-21 Warner-Lambert Company Diphenylpropanamines, compositions thereof and use thereof
ZA931601B (en) 1992-03-06 1993-10-05 Squibb & Sons Inc Microsomal triglyceride transfer protein
US5595872A (en) * 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
US5739135A (en) 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
JPH08151377A (ja) * 1994-11-25 1996-06-11 Kyowa Hakko Kogyo Co Ltd キナゾリン誘導体
US5919795A (en) 1995-06-07 1999-07-06 Pfizer Inc. Biphenyl-2-carboxylic acid-tetrahydro-isoquinolin-6-yl amide derivatives, their preparation and their use as inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (Apo B) secretion
DE19546918A1 (de) * 1995-12-15 1997-06-19 Bayer Ag Bicyclische Heterocyclen
DE19615262A1 (de) 1996-04-18 1997-10-23 Bayer Ag Heteroverknüpfte Phenylglycinolamide

Also Published As

Publication number Publication date
NO993868L (no) 1999-10-12
KR20000070983A (ko) 2000-11-25
EP0970954A4 (en) 2001-01-10
WO1999031085A1 (en) 1999-06-24
NZ337118A (en) 2000-03-27
ID23439A (id) 2000-04-20
AR009212A1 (es) 2000-04-12
EP0970954A1 (en) 2000-01-12
CA2280705A1 (en) 1999-06-24
NO993868D0 (no) 1999-08-11
HUP0001154A3 (en) 2001-06-28
TR199901933T1 (xx) 2000-03-21
PE20000054A1 (es) 2000-02-09
JPH11228569A (ja) 1999-08-24
IL131319A0 (en) 2001-01-28
JP2959765B2 (ja) 1999-10-06
HUP0001154A2 (hu) 2001-04-28
US6235730B1 (en) 2001-05-22
BR9807339A (pt) 2000-03-21
AU717963B2 (en) 2000-04-06
AU1506899A (en) 1999-07-05
CN1252068A (zh) 2000-05-03

Similar Documents

Publication Publication Date Title
SK109399A3 (en) 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same
US6200978B1 (en) Compounds as delta opioid agonists
JP5408434B2 (ja) アミド化合物
US5919795A (en) Biphenyl-2-carboxylic acid-tetrahydro-isoquinolin-6-yl amide derivatives, their preparation and their use as inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (Apo B) secretion
KR100329450B1 (ko) 신규한헤테로사이클릭화합물,이의제조방법및이를포함하는약제학적조성물
KR100269756B1 (ko) 피페리디닐티아시클릭유도체(Piperidinyl Thiacyclic Derivatives)
US20010011090A1 (en) Pyrazole derivative
RU2268882C1 (ru) Производное 4,4-дифтор-1,2,3,4-тетрагидро-5н-бензазепина, его соль и содержащая его фармацевтическая композиция
KR20040048995A (ko) 퀴놀린 화합물
JP5587246B2 (ja) レニン阻害剤としての３，４−置換ピペリジン誘導体
WO2003103669A1 (en) 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists
US20040009988A1 (en) Bioisosteric bensamide derivatives and their use as apob-100 secretion inhibitors
WO2004037817A1 (ja) Ｎ−オキシド化合物
JP7296948B2 (ja) ベンゼン縮合複素環誘導体およびその医薬組成物
JPWO2008059854A1 (ja) ピペリジン誘導体またはその塩
US20050165057A1 (en) Novel piperidine derivative
SK13292000A3 (sk) Antagonisty vitronektínového receptora, spôsob ich výroby, farmaceutický prostriedok s ich obsahom, ich použitie a medziprodukty
JP4832897B2 (ja) エステル誘導体及びその医薬用途
US20060223826A1 (en) Indole derivatives as somatostatin agonists or antagonists
SK116394A3 (en) Substituted phenylcarbamates and ureas
JP2004520348A (ja) Ｌｄｌ−受容体発現のインデューサーとしてのアリールピペリジン誘導体
JPH0533953B2 (ja)
CZ278999A3 (cs) 3-pyperidinyl-4-oxochinazolinové deriváty a farmaceutické prostředky, ve kterých jsou obsaženy
MXPA99007422A (en) 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same
EP0529365A1 (en) Diarylmethoxypiperidine derivatives